General News

Today, on Alzheimer’s Disease Awareness Day, Tianlong reaffirms its commitment to supporting those affected by Alzheimer's disease and their families. As a company dedicated to genetic testing and molecular diagnostics, Tianlong offers a cutting-edge genetic testing product aimed at identifying individuals at risk of developing Alzheimer’s through an accurate screening for the ApoE gene.

Alzheimer's disease, a progressive neurodegenerative condition, affects millions of people worldwide. It is one of the leading causes of dementia, with approximately 50 million people living with dementia globally, and this number is expected to triple by 2050 due to an aging population. Alzheimer's is characterized by memory loss, cognitive decline, and behavioral changes, significantly impacting both patients and their families. Despite ongoing research, early detection remains one of the most effective strategies to manage and slow the progression of the disease.

Genetic screening for Alzheimer's is increasingly recognized as a valuable tool in understanding disease risk. Tianlong solution for Alzheimer’s risk gene detection focuses on detecting variations in the ApoE gene, which is the strongest genetic risk factor for late-onset Alzheimer's disease. By identifying the genotype of the ApoE gene, the detection provides insight into an individual’s predisposition to developing Alzheimer's. This knowledge can enable early intervention, lifestyle adjustments, and medical guidance to reduce risk factors, offering an opportunity to manage health proactively.

As Alzheimer's Disease Awareness Day brings attention to the global impact, Tianlong continues to focus on developing advanced solutions to promote early detection and preventive care. By leveraging genetic screening technologies, Tianlong is helping both individuals and healthcare professionals better understand and manage the risk of Alzheimer’s, dedicating to bringing technology to life and making people live happier.